Pharmacological intervention in insulin resistance targeting autonomic nerve activity
Study identifier:D4411M00007
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Pharmacological intervention in insulin resistance targeting autonomic nerve activity - a concept study in mani
Medical condition
Insulin resistance
Phase
N/A
Healthy volunteers
Yes
Study drug
Atropine, Physostigmine, Placebo Sodium
Sex
All
Actual Enrollment
12
Study type
Interventional
Age
18 Years - 60 Years
Date
Study Start Date: 01 May 2007
Primary Completion Date: 01 Oct 2008
Study Completion Date: 01 Nov 2008
Study design
Allocation: Randomized
Endpoint Classification: N/A
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Basic Science
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Per-Anders Jansson
Lundberg Laboratory for diabetic research, Sahlgrenska Universitetssjukhuset Göteborg, Sweden
